These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 27133826

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Proteinuria in multiple myeloma and related diseases.
    Ganeval D, Lacour B, Chopin N, Grünfeld JP.
    Am J Nephrol; 1990; 10 Suppl 1():58-62. PubMed ID: 2124083
    [Abstract] [Full Text] [Related]

  • 3. "Idiopathic Bence-Jones proteinuria": a new characterization of an old entity.
    Mian M, Franz I, Wasle I, Herold M, Griesmacher A, Prokop W, Cortelazzo S, Gastl G, Willenbacher W, Gunsilius E, Fiegl M.
    Ann Hematol; 2013 Sep; 92(9):1263-70. PubMed ID: 23580149
    [Abstract] [Full Text] [Related]

  • 4. "Idiopathic" Bence Jones proteinuria: long-term follow-up in seven patients.
    Kyle RA, Greipp PR.
    N Engl J Med; 1982 Mar 11; 306(10):564-7. PubMed ID: 7057813
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The clinical significance of pure Bence Jones proteinuria at low concentration.
    Pezzoli A, Pascali E.
    Am J Clin Pathol; 1989 Apr 11; 91(4):473-5. PubMed ID: 2929504
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria.
    Sirohi B, Powles R, Kulkarni S, Rudin C, Saso R, Lal R, Singhal S, Mehta J, Horton C, Treleaven J.
    Bone Marrow Transplant; 2001 Jul 11; 28(1):29-37. PubMed ID: 11498741
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The incidence of Bence-Jones proteinuria in multiple myeloma.
    Pascali E, Pezzoli A.
    Br J Haematol; 1986 Dec 11; 64(4):847-50. PubMed ID: 3801327
    [No Abstract] [Full Text] [Related]

  • 15. Multiple myeloma arising from solitary plasmacytoma of bone.
    Ottó S, Végh Z, Hindy I, Péter I.
    Oncology; 1990 Dec 11; 47(1):84-6. PubMed ID: 2300391
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study.
    Sørrig R, Klausen TW, Salomo M, Vangsted AJ, Østergaard B, Gregersen H, Frølund UC, Andersen NF, Helleberg C, Andersen KT, Pedersen RS, Pedersen P, Abildgaard N, Gimsing P, Danish Myeloma Study Group.
    Eur J Haematol; 2016 Sep 11; 97(3):303-9. PubMed ID: 26710662
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [IgD myeloma. Massive Bence-Jones proteinuria; effect of the maintaining diuresis].
    Gutiérrez Fuentes JA, Fernández Remis JE, Martínez Santos MP, Romero Martínez J.
    Rev Clin Esp; 1979 Dec 31; 155(6):443-6. PubMed ID: 545493
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.